Sign Out
Pharmacotherapeutic Group: Hemofiltrates. ATC Code: B05ZB.
Pharmacology: Pharmacodynamics: Mechanism of Action: The solution is used to replace water and electrolytes removed during haemofiltration or to serve as a suitable exchange medium for use during haemodiafiltration or continuous haemodialysis. Hydrogen carbonate is used as an alkalising buffer.
Pharmacodynamic Effects: Prismasol B0 is pharmacologically inactive. The sodium, calcium, magnesium and chloride ions are present at concentrations similar to physiological levels in plasma.
Pharmacokinetics: Not relevant. The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.
Toxicology: Preclinical Safety Data: Not relevant. The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.
